Bacillus coagulans is a spore-forming probiotic that solves the #1 problem with traditional probiotics: survivability. Most Lactobacillus/Bifidobacterium probiotics are killed by stomach acid, heat, and storage conditions (only 1-10% of non-spore-forming probiotics survive transit). B. coagulans spores survive 100°C boiling, stomach acid (pH 2), and room temperature storage indefinitely. Our research shows it has moderate evidence for IBS symptom reduction, post-antibiotic gut restoration, and rheumatoid arthritis joint pain improvement. The specific strain GBI-30, 6086 (GanedenBC30) has the most clinical data.
B. coagulans forms an endospore — a metabolically dormant protective shell that makes it resistant to heat, acid, pressure, and desiccation. Upon reaching the small intestine, bile salts trigger spore germination into active vegetative cells that: (1) produce L-lactic acid (lowers intestinal pH, inhibiting pathogen growth); (2) produce bacteriocins (antimicrobial peptides against pathogens); (3) compete with pathogens for adhesion sites on intestinal epithelium; (4) stimulate immune cells (dendritic cells, T-cells) in gut-associated lymphoid tissue (GALT). Unlike Lactobacillus, B. coagulans doesn't need to survive the stomach — it's already evolved to pass through as a spore and germinate where it matters.
No critical interactions identified.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.